Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)

Clinical trial NCT07146022 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07146022
Sponsor: Veradermics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Androgenetic Alopecia (AGA)Androgenetic Alopecia AGA Female Androgenetic Alopecia Hair Loss

Start date: 2025-07-25
Primary completion: 2027-06-01
Enrollment: 552

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.